Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia.
Trad R, Warda W, Alcazer V, Neto da Rocha M, Berceanu A, Nicod C, Haderbache R, Roussel X, Desbrosses Y, Daguindau E, Renosi F, Roumier C, Bouquet L, Biichle S, Guiot M, Seffar E, Caillot D, Depil S, Robinet E, Salma Y, Deconinck E, Deschamps M, Ferrand C.
Trad R, et al. Among authors: nicod c.
J Immunother Cancer. 2022 Jul;10(7):e004222. doi: 10.1136/jitc-2021-004222.
J Immunother Cancer. 2022.
PMID: 35803613
Free PMC article.